Trial Profile
A retrospective trial to assess Real-World Treatment Persistence with Vedolizumab in Patients with Ulcerative Colitis and Crohn's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jan 2017
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 06 Jan 2017 New trial record